The breakthrough potential of aptamer therapeutics
Since their initial explosion onto the market, there is a growing pipeline demonstrating the promise of aptamer therapeutics across…
Since their initial explosion onto the market, there is a growing pipeline demonstrating the promise of aptamer therapeutics across…
AptaBlot – increasing the utility of Western Blotting Western Blotting is a powerful technique used to detect and identify proteins. Antibodies have traditionally been used as the detection…
The world is currently gripped by the novel COVID-19 crisis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is a highly pathogenic viral respiratory illness. It is…
25/11/2020 Aptamer Group Ltd, the developer of diagnostic and therapeutic aptamer reagents, is pleased to announce further progress in their collaboration with Integumen plc (AIM: SKIN) to develop Microtox PD,…
Biomarker Discovery A biomarker is a measurable indicator showing the presence or severity of a disease state. Using biomarkers to differentiate between healthy and diseased cells can enable…
28/09/2020 Collaboration to produce a rapid test for the COVID-19 coronavirus infection Aptamer Group, is pleased to announce that it has entered into a collaboration with Cytiva,…
09/07/2020 Collaboration to use aptamers in a device to detect SARS-CoV-2 in wastewater Aptamer Group, developers of Aptamer reagents, is pleased to announce that it has signed…
Arron Tolley, CEO of Aptamer Group discusses the teams progress on COVID-19 tests: 17/06/2020 Scientists at York-based biotechnology company Aptamer Group are using their expertise to develop a COVID-19…